Literature DB >> 18485316

Outcomes of epilepsy surgery in adults and children.

Susan Spencer1, Linda Huh.   

Abstract

Surgery is widely accepted as an effective therapy for selected individuals with medically refractory epilepsy. Numerous studies in the past 20 years have reported seizure freedom for at least 1 year in 53-84% of patients after anteromesial temporal lobe resections for mesial temporal lobe sclerosis, in 66-100% of patients with dual pathology, in 36-76% of patients with localised neocortical epilepsy, and in 43-79% of patients after hemispherectomies. Reported rates for non-resective surgery have been less impressive in terms of seizure freedom; however, the benefit is more apparent when reported in terms of significant seizure reductions. In this Review, we consider the outcomes of surgery in adults and children with epilepsy and review studies of neurological and cognitive sequelae, psychiatric and behavioural outcomes, and overall health-related quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18485316     DOI: 10.1016/S1474-4422(08)70109-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  153 in total

1.  Ictal asystole and ictal syncope: insights into clinical management.

Authors:  Michael Bestawros; Dawood Darbar; Amir Arain; Bassel Abou-Khalil; Dale Plummer; William D Dupont; Satish R Raj
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-12

2.  Prediction of Postsurgical Neuropsychological Outcome: Increasing Options.

Authors:  William Barr
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

3.  Optical control of focal epilepsy in vivo with caged γ-aminobutyric acid.

Authors:  Xiaofeng Yang; Daniel L Rode; Darcy S Peterka; Rafael Yuste; Steven M Rothman
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

4.  Stereotactic electroencephalography with temporal grid and mesial temporal depth electrode coverage: does technique of depth electrode placement affect outcome?

Authors:  Jamie J Van Gompel; Fredric B Meyer; W Richard Marsh; Kendall H Lee; Gregory A Worrell
Journal:  J Neurosurg       Date:  2010-07       Impact factor: 5.115

5.  Effect of invasive EEG monitoring on cognitive outcome after left temporal lobe epilepsy surgery.

Authors:  Robyn M Busch; Thomas E Love; Lara E Jehi; Lisa Ferguson; Ruta Yardi; Imad Najm; William Bingaman; Jorge Gonzalez-Martinez
Journal:  Neurology       Date:  2015-09-25       Impact factor: 9.910

6.  Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.

Authors:  Jonathan H Hecht; Julie A Siegenthaler; Katelin P Patterson; Samuel J Pleasure
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

7.  Current dipole orientation and distribution of epileptiform activity correlates with cortical thinning in left mesiotemporal epilepsy.

Authors:  Claus Reinsberger; Naoaki Tanaka; Andrew J Cole; Jong Woo Lee; Barbara A Dworetzky; Edward B Bromfield; Lorie Hamiwka; Blaise F Bourgeois; Alexandra J Golby; Joseph R Madsen; Steven M Stufflebeam
Journal:  Neuroimage       Date:  2010-05-21       Impact factor: 6.556

8.  Graph Theory Analysis of Functional Connectivity Combined with Machine Learning Approaches Demonstrates Widespread Network Differences and Predicts Clinical Variables in Temporal Lobe Epilepsy.

Authors:  Mohsen Mazrooyisebdani; Veena A Nair; Camille Garcia-Ramos; Rosaleena Mohanty; Elizabeth Meyerand; Bruce Hermann; Vivek Prabhakaran; Raheel Ahmed
Journal:  Brain Connect       Date:  2020-02

Review 9.  Toward a Mechanistic Understanding of Epileptic Networks.

Authors:  Elliot H Smith; Catherine A Schevon
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

Review 10.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.